Triglycerides and EPA: A New Chapter in CV Disease Prevention
Findings from REDUCE-IT are the first to show that EPA lowers the relative risk of hard cardiovascular endpoints. Johns Hopkins' Seth Martin, MD, and colleagues put the trial in perspective.
JUPITER: How will it impact future statin guidelines?
2 Commerce Drive Cranbury, NJ 08512